FDA Approves Xeomin for Excessive Drooling, Common in ALS Patients
Xeomin (incobotulinumtoxinA) has been approved by the U.S. Food and Drug Administration for the treatment of chronic sialorrhea, or excessive drooling, a…
Articles by Kara Elam
Neuroimaging Techniques Confirm Neuropathological Findings that Contribute to Degeneration in ALS
Advanced neuroimaging techniques and neuropsychological evaluations of patients with amyotrophic lateral sclerosis (ALS) recently confirmed the existence of a unique…
ALS Phase 3 Study of Masitinib Reaches Target Patient Enrollment
AB Science recently announced it has completed its targeted enrollment of 381 patients for an ongoing Phase 3 study evaluating masitinib in the…
ALS Neuroscience Focus Turns to Promising RNA Research
This week the ALS Association, whose mission is to lead the fight to treat and cure ALS through global…
Study Findings Reveal Key Genetic Piece of ALS And Dementia Puzzle
University of Toronto (UT) researchers have uncovered the main genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia…
Protein Misfolding and Mitochondrial Dysfunction in ALS Pathogenesis
Researchers from the University of Milan (UM), Italy, have recently released findings from their scientific literature review, in an effort to uncover the…
ALS Ice Bucket Challenge Returning This August to Raise Research Money
Last year a monumental push to increase research funding for Amyotrophic Lateral Sclerosis (ALS), known as the ALS Ice Bucket…
Study Findings May Lead To Future Genetic Test For ALS
Researchers from the University of Toronto (UT) have recently discovered a potential way to detect a genetic predisposition for…
Exposure to Low-Frequency Magnetic Fields is not an Alzheimer’s or ALS Risk Factor
Researchers from the Institute of Pathobiochemistry at the Medical Center of Johannes Gutenberg University Mainz, Germany, have recently released…
Kadimastem To Initiate a Human Clinical Trial for Promising ALS Therapy
This week, Kadimastem, an innovative Israeli biotechnology company focused on the industrial development and commercialization of human pluripotent stem…